TearSolutions
Charlottesville, US · Founded 2015 · Delaware corporation · 2 known investors
Biotechin /tearsolutions-llc
Founders & leadership
GW
Gordon W LaurieExecutive Officer
CM
Colin M RolphExecutive Officer
RJ
Robert J DempseyExecutive Officer, Director
AA
Anil AsraniExecutive Officer, Director
BK
Bruce KuperDirector
TG
Thomas GadekExecutive Officer, Director
LM
Louis M AlpernDirector
JR
James RameyDirector
JB
Jens BiertumpelDirector
KD
Konstantine DrakonakisDirector
MB
Mark B LoganDirector
AS
Amir ShojaeiDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$517KraisedNov 2025 · 12 investors · BiotechnologyRule 506(b)
▶$517KraisedNov 2025 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James M RameyDirector
- Amir W ShojaeiDirector
- Colin M RolphExecutive Officer
- Gordon W LaurieExecutive Officer
- Robert J DempseyExecutive Officer, Director
- Mark B LoganDirector
- Anil W AsraniExecutive Officer, Director
- Jens BiertumpelDirector
- Louis M AlpernDirector
- Offering amount
- $517K
- Amount sold
- $517K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.7MraisedOct 2024 · 80 investors · BiotechnologyRule 506(b)
▶$12.7MraisedOct 2024 · 80 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jens BiertumpelDirector
- Colin M RolphExecutive Officer
- Mark B LoganDirector
- Anil AsraniExecutive Officer, Director
- Robert J DempseyExecutive Officer, Director
- Gordon W LaurieExecutive Officer
- Louis M AlpernDirector
- James RameyDirector
- Amir ShojaeiDirector
- Offering amount
- $14M
- Amount sold
- $12.7M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$390KraisedAug 2024 · 10 investors · BiotechnologyRule 506(b)
▶$390KraisedAug 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Louis M AlpernDirector
- James RameyDirector
- Colin M RolphExecutive Officer
- Mark B LoganDirector
- Amir ShojaeiDirector
- Robert J DempseyExecutive Officer, Director
- Jens BiertumpelDirector
- Anil AsraniExecutive Officer, Director
- Gordon W LaurieExecutive Officer
- Offering amount
- $3M
- Amount sold
- $390K
- Minimum investment
- $25K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedJan 2022 · 44 investors · BiotechnologyRule 506(b)
▶$5.6MraisedJan 2022 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anil AsraniExecutive Officer, Director
- Alexey ChernushkinDirector
- Laurie GordonExecutive Officer
- Bruce P. KupperDirector
- Michelle CarpenterExecutive Officer
- Mac ThompsonExecutive Officer
- Marc OdrichExecutive Officer
- Mark B. LoganExecutive Officer, Director
- Leonard BorrmannDirector
- Colin RolphExecutive Officer
- Jens BiertumpelDirector
- Offering amount
- $7M
- Amount sold
- $5.6M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2020 · 36 investors · BiotechnologyRule 506(b)
▶$1.5MraisedFeb 2020 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas GadekExecutive Officer, Director
- Gordon LaurieExecutive Officer
- Colin RolphExecutive Officer
- Marc OdrichExecutive Officer
- Michelle CarpenterExecutive Officer
- Jens BiertumpelDirector
- John MooreExecutive Officer
- Bruce KupperDirector
- William McIlwaine Thompson, Jr.Executive Officer
- Alexey VinogradovDirector
- Mark LoganExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.3MraisedApr 2019 · 16 investors · BiotechnologyRule 506(b)
▶$1.3MraisedApr 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John MooreExecutive Officer
- Bruce KupperDirector
- Colin RolphExecutive Officer
- Gordon LaurieExecutive Officer
- Thomas GadekExecutive Officer, Director
- William McIlwaine Thompson, Jr.Executive Officer
- Marc OdrichExecutive Officer
- Mark LoganExecutive Officer, Director
- Jens BiertumpelDirector
- Alexey VinogradovDirector
- Michelle CarpenterExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$5.1MraisedApr 2019 · 22 investors · BiotechnologyRule 506(b)
▶$5.1MraisedApr 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jens BiertumpelDirector
- Alexey VinogradovDirector
- William McIlwaine Thompson, Jr.Executive Officer
- Bruce KupperDirector
- John MooreExecutive Officer
- Mark LoganExecutive Officer, Director
- Michelle CarpenterExecutive Officer
- Marc OdrichExecutive Officer
- Colin RolphExecutive Officer
- Thomas GadekExecutive Officer, Director
- Gordon LaurieExecutive Officer
- Offering amount
- $5.1M
- Amount sold
- $5.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$8.1MraisedDec 2017 · 24 investors · BiotechnologyRule 506(b)
▶$8.1MraisedDec 2017 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- W. McIlwaine Thompson, Jr.Executive Officer
- Mark LoganDirector
- Colin RolphExecutive Officer
- Alexey VinogradovDirector
- Tom GadekExecutive Officer, Director
- Bruce KupperDirector
- Offering amount
- $9.2M
- Amount sold
- $8.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.